Notes from the lab — platform updates, publications, and the occasional detour.
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
We keep molecular targets confidential pre-patent, but we try to be transparent about the mechanism class…
Cell therapy's biggest bottleneck isn't the science. It's turning a bespoke, patient-specific product into something repeatable.
A failed dose-escalation cohort taught us more about manufacturing variability than any of our successes did.
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!